These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22238500)

  • 1. Combination treatment with oxaliplatin and mangiferin causes increased apoptosis and downregulation of NFκB in cancer cell lines.
    du Plessis-Stoman D; du Preez J; van de Venter M
    Afr J Tradit Complement Altern Med; 2011; 8(2):177-84. PubMed ID: 22238500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms underlying mangiferin-induced apoptosis and cell cycle arrest in A549 human lung carcinoma cells.
    Shi W; Deng J; Tong R; Yang Y; He X; Lv J; Wang H; Deng S; Qi P; Zhang D; Wang Y
    Mol Med Rep; 2016 Apr; 13(4):3423-32. PubMed ID: 26935347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sesquiterpene lactone parthenolide markedly enhances sensitivity of human A549 cells to low-dose oxaliplatin via inhibition of NF-kappaB activation and induction of apoptosis.
    Fang LJ; Shao XT; Wang S; Lu GH; Xu T; Zhou JY
    Planta Med; 2010 Feb; 76(3):258-64. PubMed ID: 19774508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mangiferin induces apoptosis by suppressing Bcl-xL and XIAP expressions and nuclear entry of NF-κB in HL-60 cells.
    Shoji K; Tsubaki M; Yamazoe Y; Satou T; Itoh T; Kidera Y; Tanimori Y; Yanae M; Matsuda H; Taga A; Nakamura H; Nishida S
    Arch Pharm Res; 2011 Mar; 34(3):469-75. PubMed ID: 21547680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-D-Glucoside suppresses tumor necrosis factor-induced activation of nuclear transcription factor kappaB but potentiates apoptosis.
    Sarkar A; Sreenivasan Y; Ramesh GT; Manna SK
    J Biol Chem; 2004 Aug; 279(32):33768-81. PubMed ID: 15161907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells.
    Serova M; Calvo F; Lokiec F; Koeppel F; Poindessous V; Larsen AK; Laar ES; Waters SJ; Cvitkovic E; Raymond E
    Cancer Chemother Pharmacol; 2006 Apr; 57(4):491-9. PubMed ID: 16075278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mangiferin induces apoptosis in multiple myeloma cell lines by suppressing the activation of nuclear factor kappa B-inducing kinase.
    Takeda T; Tsubaki M; Kino T; Yamagishi M; Iida M; Itoh T; Imano M; Tanabe G; Muraoka O; Satou T; Nishida S
    Chem Biol Interact; 2016 May; 251():26-33. PubMed ID: 26996543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxaliplatin sensitizes human colon cancer cells to TRAIL through JNK-dependent phosphorylation of Bcl-xL.
    El Fajoui Z; Toscano F; Jacquemin G; Abello J; Scoazec JY; Micheau O; Saurin JC
    Gastroenterology; 2011 Aug; 141(2):663-73. PubMed ID: 21683075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mangiferin enhances the sensitivity of human multiple myeloma cells to anticancer drugs through suppression of the nuclear factor κB pathway.
    Takeda T; Tsubaki M; Kino T; Kawamura A; Isoyama S; Itoh T; Imano M; Tanabe G; Muraoka O; Matsuda H; Satou T; Nishida S
    Int J Oncol; 2016 Jun; 48(6):2704-12. PubMed ID: 27035859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Honokiol augments the anti-cancer effects of oxaliplatin in colon cancer cells.
    Hua H; Chen W; Shen L; Sheng Q; Teng L
    Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):773-9. PubMed ID: 23786838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines.
    Ginés A; Bystrup S; Ruiz de Porras V; Guardia C; Musulén E; Martínez-Cardús A; Manzano JL; Layos L; Abad A; Martínez-Balibrea E
    PLoS One; 2015; 10(5):e0123830. PubMed ID: 25955657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mangiferin and Cancer: Mechanisms of Action.
    Gold-Smith F; Fernandez A; Bishop K
    Nutrients; 2016 Jun; 8(7):. PubMed ID: 27367721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Goniothalamin induces cell cycle arrest and apoptosis in H400 human oral squamous cell carcinoma: A caspase-dependent mitochondrial-mediated pathway with downregulation of NF-κβ.
    Li LK; Rola AS; Kaid FA; Ali AM; Alabsi AM
    Arch Oral Biol; 2016 Apr; 64():28-38. PubMed ID: 26752226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells.
    Plasencia C; Martínez-Balibrea E; Martinez-Cardús A; Quinn DI; Abad A; Neamati N
    Int J Oncol; 2006 Jul; 29(1):225-35. PubMed ID: 16773204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering of caveolae-specific self-micellizing anticancer lipid nanoparticles to enhance the chemotherapeutic efficacy of oxaliplatin in colorectal cancer cells.
    Sundaramoorthy P; Ramasamy T; Mishra SK; Jeong KY; Yong CS; Kim JO; Kim HM
    Acta Biomater; 2016 Sep; 42():220-231. PubMed ID: 27395829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of NF-kappaB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) or oxaliplatin.
    Jani TS; DeVecchio J; Mazumdar T; Agyeman A; Houghton JA
    J Biol Chem; 2010 Jun; 285(25):19162-72. PubMed ID: 20424169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity and modes of action of three naturally occurring xanthones (8-hydroxycudraxanthone G, morusignin I and cudraxanthone I) against sensitive and multidrug-resistant cancer cell lines.
    Kuete V; Sandjo LP; Ouete JL; Fouotsa H; Wiench B; Efferth T
    Phytomedicine; 2014 Feb; 21(3):315-22. PubMed ID: 24075210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of G1/S transition potentiates oxaliplatin-induced cell death in colon cancer cell lines.
    Rakitina TV; Vasilevskaya IA; O'Dwyer PJ
    Biochem Pharmacol; 2007 Jun; 73(11):1715-26. PubMed ID: 17343830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of JNK Sensitizes Hypoxic Colon Cancer Cells to DNA-Damaging Agents.
    Vasilevskaya IA; Selvakumaran M; Hierro LC; Goldstein SR; Winkler JD; O'Dwyer PJ
    Clin Cancer Res; 2015 Sep; 21(18):4143-52. PubMed ID: 26023085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of p110β expression increases chemosensitivity of colon cancer cell lines to oxaliplatin.
    Liu W; Wang G; Cao X; Luo X; Li Z; Deng Y; Li X; Wang S; Liu M; Hu J; Wang J
    J Huazhong Univ Sci Technolog Med Sci; 2012 Apr; 32(2):280-286. PubMed ID: 22528234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.